Title of article :
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
Author/Authors :
Nish Chaturvedi، نويسنده , , Massimo Porta، نويسنده , , Ronald Klein، نويسنده , , Trevor Orchard، نويسنده , , John Fuller، نويسنده , , Hans-Henrik Parving، نويسنده , , Rudy Bilous، نويسنده , , Anne-Katrin Sjolie، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2008
Pages :
9
From page :
1394
To page :
1402
Abstract :
Summary Background Results of previous studies suggest that renin-angiotensin system blockers might reduce the burden of diabetic retinopathy. We therefore designed the DIabetic REtinopathy Candesartan Trials (DIRECT) Programme to assess whether candesart
Journal title :
The Lancet
Serial Year :
2008
Journal title :
The Lancet
Record number :
593606
Link To Document :
بازگشت